Drug:
Reaction: ASTHMA
20260101 - 20261231
No. 501 - 600
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 501 | 26852271 |
US |
||
Product odour abnormal, Product taste abnormal, Drug ineffective, Dyspnoea, Asthma, Fatigue, Product supply issue, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 502 | 26852379 |
US |
66 | 2 |
Influenza, Asthma, |
||||
DUPILUMAB, |
||||
| 503 | 26852606 |
US |
15 | 2 |
Dry skin, Asthma, Pruritus, Skin exfoliation, |
||||
DUPILUMAB, DUPILUMAB, ALBUTEROL SULFATE, ALBUTEROL SULFATE, EPINEPHRINE, ADRENALINUM, FLUOXETINE HYDROCHLORIDE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, MONTELUKAST SODIUM, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, |
||||
| 504 | 26852607 |
US |
33 | 2 |
Dermatitis, Bronchitis, Asthma, Dermatitis atopic, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, BENRALIZUMAB, |
||||
| 505 | 26852823 |
US |
2 | |
Asthma, Pulmonary congestion, Chest discomfort, Dyspnoea, Cough, Migraine, |
||||
BRENSOCATIB, BRENSOCATIB, NAPROXEN SODIUM, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, GUAIFENESIN, NAPROXEN SODIUM, PSEUDOEPHEDRINE HYDROCHLORIDE, ALBUTEROL SULFATE, ALBUTEROL, AZTREONAM, |
||||
| 506 | 26852846 |
US |
2 | |
Asthma, Sinusitis, Ear infection, Bronchitis, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 507 | 26852866 |
US |
71 | 1 |
Asthma, Cough, Therapeutic response decreased, |
||||
DUPILUMAB, |
||||
| 508 | 26852871 |
US |
15 | 2 |
Asthma, |
||||
DUPILUMAB, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 509 | 26853163 |
US |
53 | 1 |
Asthma, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 510 | 26853365 |
GB |
2 | |
Pneumonia fungal, Pneumonia, Asthma, Syncope, Ankylosing spondylitis, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 511 | 26853369 |
US |
64 | 2 |
Asthma, |
||||
DUPILUMAB, |
||||
| 512 | 26853770 |
US |
78 | 2 |
Asthma, |
||||
DUPILUMAB, |
||||
| 513 | 26854131 |
US |
24 | 2 |
Rhinitis allergic, Dermatitis atopic, Asthma, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 514 | 26854467 |
US |
40 | 2 |
Asthma, |
||||
DUPILUMAB, |
||||
| 515 | 26854478 |
US |
1 | |
Asthma, Middle insomnia, Loss of personal independence in daily activities, Product dose omission issue, |
||||
DUPILUMAB, ALBUTEROL SULFATE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, CARVEDILOL, IPRATROPIUM BROMIDE AND ALBUTEROL, HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM, LOSARTAN, |
||||
| 516 | 26854509 |
CA |
64 | 2 |
Viral infection, Forced expiratory volume decreased, Middle insomnia, Weight increased, Asthma, Illness, Inappropriate schedule of product administration, Pulmonary function test decreased, Obstructive airways disorder, Reaction to excipient, Nasopharyngitis, Hypertonic bladder, Upper respiratory tract infection, Anaphylactic reaction, Product dose omission issue, Hypersensitivity, Mast cell activation syndrome, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, ALBUTEROL SULFATE, |
||||
| 517 | 26854536 |
US |
44 | 2 |
Asthma, |
||||
DUPILUMAB, |
||||
| 518 | 26854799 |
CA |
43 | 2 |
Abdominal discomfort, Adjustment disorder with depressed mood, Asthma, Chest pain, Contusion, Drug-induced liver injury, Dyspepsia, Gait inability, Inflammation, Lip dry, Lower respiratory tract infection, Lung disorder, Migraine, Muscle spasms, Paraesthesia, Type 2 diabetes mellitus, Upper respiratory tract infection, Urticaria, Visual impairment, Vomiting, Weight decreased, Weight increased, Wheezing, Wound, Wound infection, Prescribed underdose, Product use issue, |
||||
PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, TOFACITINIB, TOFACITINIB, INFLIXIMAB, INFLIXIMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MESALAMINE, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, AZATHIOPRINE, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CHLORHEXIDINE GLUCONATE, CHLORHEXIDINE GLUCONATE, DESOXIMETASONE, DESOXIMETASONE, GOLIMUMAB, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, MORPHINE SULFATE, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, APREMILAST, APREMILAST, APREMILAST, OXYCODONE, PREGABALIN, SALICYLIC ACID, MEDICATED CORN REMOVERS, LIQUID WART REMOVER, ULTRA THIN CORN REMOVERS, EXTRA THICK CALLUS REMOVERS, MEDICATED WART REMOVERS, CORN AND CALLUS REMOVER KIT, WART REMOVERS, WART REMOVER LIQUID, MEDICATED CALLUS REMOVERS, WART REMOVER GEL, MEDICATED PLANTAR WART REMOVER, MEDICATED CALLUS REMOVERS EXTRA THICK, MEDICATED CORN REMOVER, WART REMOVER, CLEAR MEDICATED CORN REMOVERS, CORN REMOVERS, BOSYE BENEFITING HAIR LOTION, LIQUID CORN AND CALLUS REMOVER, WART REMOVER MEDICATED DISCS, WART REMOVER GEL TUBE, SALICYLIC ACID 12%, CALLUS REMOVERS, CORN AND CALLUS REMOVER, GEL CORN REMOVER, ASTRINGENT, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TRAMADOL HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRICLOSAN, USTEKINUMAB, |
||||
| 519 | 26855679 |
US |
73 | 2 |
Asthma, Pruritus, Skin ulcer, Dyspnoea, Lip swelling, Rash, Product physical issue, Swollen tongue, Wrong technique in product usage process, Alopecia, |
||||
PANCRELIPASE, PANCRELIPASE, PANCRELIPASE, |
||||
| 520 | 26855858 |
US |
62 | 2 |
Asthma, Anxiety, Bronchitis chronic, Fibromyalgia, Blood pressure increased, |
||||
DENOSUMAB, ERENUMAB-AOOE, TEZEPELUMAB-EKKO, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, HYDROCORTISONE, DULOXETINE HYDROCHLORIDE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, FEXOFENADINE HYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE ORAL, FEXOFENADINE HCL, GABAPENTIN, HYDROXYCHLOROQUINE SULFATE, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, LOSARTAN POTASSIUM, LOSARTAN, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, PROGESTERONE, ROSUVASTATIN CALCIUM, TRAMADOL HYDROCHLORIDE, |
||||
| 521 | 26855995 |
US |
2 | |
Asthma, |
||||
DUPILUMAB, |
||||
| 522 | 26856397 |
CA |
47 | 2 |
Asthma, Neck pain, Drug dose omission by device, Arthralgia, Fatigue, Product delivery mechanism issue, |
||||
GLATIRAMER ACETATE, CALCIUM, CALCIUM, VENLAFAXINE HYDROCHLORIDE, CLONAZEPAM, ALBUTEROL SULFATE, ERGOCALCIFEROL, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, |
||||
| 523 | 26856465 |
US |
72 | 2 |
Asthma, Injection site pain, |
||||
DUPILUMAB, |
||||
| 524 | 26857326 |
US |
70 | 2 |
Asthma, Constipation, Therapy change, |
||||
BENRALIZUMAB, BENRALIZUMAB, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, LEVOCETIRIZINE DIHYDROCHLORIDE, MONTELUKAST SODIUM, INSULIN GLARGINE, INSULIN HUMAN, LOSARTAN POTASSIUM, LOSARTAN, MEPOLIZUMAB, |
||||
| 525 | 26846776 |
US |
1 | |
Gastrooesophageal reflux disease, Dyspnoea, Erythema, Asthma, |
||||
DUPILUMAB, |
||||
| 526 | 26846783 |
US |
1 | |
Asthma, |
||||
DUPILUMAB, |
||||
| 527 | 26847046 |
CA |
2 | |
Asthma, Chest discomfort, Cough, Dyspnoea, Full blood count abnormal, Nasal polyps, Obstructive airways disorder, Paranasal sinus inflammation, Productive cough, Respiratory tract infection, Sinusitis, Sleep disorder due to a general medical condition, Sputum purulent, Wheezing, Therapeutic product effect incomplete, |
||||
LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, CICLESONIDE, PREDNISONE, CICLESONIDE, MOMETASONE FUROATE, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 528 | 26847880 |
US |
30 | 2 |
Asthma, |
||||
DUPILUMAB, |
||||
| 529 | 26847904 |
US |
65 | 2 |
Asthma, |
||||
DUPILUMAB, |
||||
| 530 | 26847976 |
US |
2 | |
Unevaluable event, Rash, Pruritus, Asthma, Dyspnoea, Cough, Headache, COVID-19, |
||||
TEZEPELUMAB-EKKO, TEZEPELUMAB-EKKO, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 531 | 26848234 |
US |
42 | 2 |
Asthma, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 532 | 26848235 |
US |
2 | |
Influenza, Asthma, |
||||
DUPILUMAB, |
||||
| 533 | 26848265 |
JP |
64 | 1 |
Retinal artery occlusion, Eosinophilic granulomatosis with polyangiitis, Polyneuropathy, Retinal thickening, Asthma, Chronic rhinosinusitis with nasal polyps, Sensory disturbance, Visual field defect, Eosinophilia, Retinal disorder, Obstructive airways disorder, Mononeuropathy multiplex, Sinus disorder, Visual acuity reduced, Prescribed underdose, Off label use, |
||||
MEPOLIZUMAB, MEPOLIZUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 534 | 26848822 |
CA |
2 | |
Pulmonary congestion, Asthma, Pulmonary mass, Neuropathy peripheral, Productive cough, Dyspnoea, Blood glucose decreased, Pleural effusion, Hernia, |
||||
LEFLUNOMIDE, ADALIMUMAB-FKJP, ADALIMUMAB-FKJP, |
||||
| 535 | 26849013 |
US |
2 | |
Asthma, |
||||
DUPILUMAB, |
||||
| 536 | 26849017 |
US |
79 | 2 |
Asthma, Nasal congestion, Foreign body in respiratory tract, |
||||
DUPILUMAB, |
||||
| 537 | 26849472 |
CA |
80 | 1 |
Anaemia, Abdominal distension, Abdominal pain, Activated partial thromboplastin time prolonged, Analgesic therapy, Malignant melanoma stage 0, Antacid therapy, Anticoagulant therapy, Aortic stenosis, Appendicitis, Appendicolith, Ascites, Aspartate aminotransferase increased, Aspiration, Asthenia, Asthma, Bacterial infection, Benign prostatic hyperplasia, Blood calcium increased, Blood cholesterol increased, Blood creatinine increased, Blood phosphorus increased, Blood test abnormal, Blood uric acid increased, Breath sounds abnormal, Bronchopulmonary aspergillosis allergic, Cardiogenic shock, Chronic obstructive pulmonary disease, Cardiovascular disorder, Congenital hiatus hernia, Constipation, Condition aggravated, Coronary artery disease, Diabetes mellitus, Drug hypersensitivity, Drug ineffective, Drug intolerance, Drug therapy, Dry mouth, Dyspnoea, End stage renal disease, Fatigue, Full blood count abnormal, Gastrointestinal disorder, General physical health deterioration, Headache, Gout, Hypercholesterolaemia, Hyperlipidaemia, Hyperphosphataemia, Hypertension, Hyponatraemia, Incorrect route of product administration, Hypophosphataemia, Intentional product misuse, Intentional product misuse, Iron deficiency, Joint injury, Liver disorder, Lower respiratory tract infection, Lung disorder, Micturition urgency, Multiple organ dysfunction syndrome, Musculoskeletal stiffness, Myasthenia gravis, Nausea, Neuralgia, Oedema peripheral, Off label use, Pain, Pleuritic pain, Product use in unapproved indication, Product dose omission issue, Pulmonary embolism, Pyrexia, Respiratory symptom, Sepsis, Sleep disorder, Sleep disorder therapy, Somnolence, Stress, Swelling, Thrombosis, Transaminases increased, Transient ischaemic attack, Tremor, Troponin increased, Ulcer, Upper respiratory tract infection, Ventricular fibrillation, Vomiting, |
||||
AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE, CEFTRIAXONE SODIUM, CEFTRIAXONE SODIUM, CEFTRIAXONE SODIUM, CEFTRIAXONE SODIUM, CEFTRIAXONE SODIUM, CEFTRIAXONE SODIUM, DOBUTAMINE HYDROCHLORIDE, DOBUTAMINE HYDROCHLORIDE, DOBUTAMINE HYDROCHLORIDE, DOBUTAMINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ALLOPURINOL SODIUM, ALLOPURINOL SODIUM, ALLOPURINOL SODIUM, ALLOPURINOL SODIUM, DARBEPOETIN ALFA, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 3350, DALTEPARIN SODIUM, DALTEPARIN SODIUM, DARBEPOETIN ALFA, DARBEPOETIN ALFA, DARBEPOETIN ALFA, DARBEPOETIN ALFA, DARBEPOETIN ALFA, DARBEPOETIN ALFA, DARBEPOETIN ALFA, DEXLANSOPRAZOLE, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, DALTEPARIN SODIUM, DALTEPARIN SODIUM, MEPOLIZUMAB, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 538 | 26849752 |
US |
64 | 2 |
Weight increased, Asthma, Dyspnoea, |
||||
DUPILUMAB, |
||||
| 539 | 26850081 |
US |
2 | |
Asthma, |
||||
DUPILUMAB, PREDNISONE, |
||||
| 540 | 26850112 |
US |
69 | 2 |
Sinusitis, Cough, Sneezing, Hypersensitivity, Asthma, Drug ineffective, |
||||
DUPILUMAB, |
||||
| 541 | 26850136 |
US |
61 | 2 |
Asthma, Dyspnoea, Hip arthroplasty, |
||||
DUPILUMAB, |
||||
| 542 | 26850423 |
US |
1 | |
Asthma, Stress, |
||||
DUPILUMAB, |
||||
| 543 | 26850780 |
US |
2 | |
Productive cough, Drainage, Back pain, Dyspnoea, Asthma, Arthralgia, |
||||
DUPILUMAB, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AZELASTINE HYDROCHLORIDE, AZELASTINE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, FAMOTIDINE, HYDROCHLOROTHIAZIDE, LEVOCETIRIZINE DIHYDROCHLORIDE, MONTELUKAST SODIUM, MONTELUKAST, PRAVASTATIN SODIUM, ERGOCALCIFEROL, FLUTICASONE PROPIONATE AND SALMETEROL, |
||||
| 544 | 26851200 |
CN |
63 | 2 |
Asthma, Drug ineffective, Product use issue, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, GLIPIZIDE, CANAGLIFLOZIN, |
||||
| 545 | 26851387 |
US |
71 | 2 |
Dyspnoea, Sleep disorder due to a general medical condition, Asthma, Chronic obstructive pulmonary disease, |
||||
DUPILUMAB, |
||||
| 546 | 26851891 |
US |
79 | 1 |
Bronchiectasis, Asthma, Device intolerance, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 547 | 26854979 |
67 | 2 | |
Asthma, Dyspnoea, Carbon dioxide increased, |
||||
MEPOLIZUMAB, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, MONTELUKAST, |
||||
| 548 | 26845889 |
US |
70 | 1 |
Asthma, |
||||
DUPILUMAB, |
||||
| 549 | 26845932 |
CA |
2 | |
Asthma, Nasopharyngitis, |
||||
MEPOLIZUMAB, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, ALBUTEROL SULFATE, |
||||
| 550 | 26845970 |
US |
7 | 1 |
Asthma, Dyspnoea, Incorrect dose administered, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 551 | 26846164 |
US |
64 | 2 |
Asthma, |
||||
DUPILUMAB, |
||||
| 552 | 26846340 |
US |
2 | |
Asthma, Blood pressure abnormal, |
||||
DUPILUMAB, CALCIUM, DAPAGLIFLOZIN, IRON, ATORVASTATIN CALCIUM, LISINOPRIL, MECLIZINE HYDROCHLORIDE, MECLIZINE, MECLIZINE HYDROCLORIDE, SERTRALINE HYDROCHLORIDE, MONTELUKAST SODIUM, LEVOTHYROXINE SODIUM, ERGOCALCIFEROL, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, |
||||
| 553 | 26846589 |
US |
58 | 1 |
Asthma, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 554 | 26844986 |
US |
27 | 1 |
Asthma, Dyspnoea, |
||||
DUPILUMAB, |
||||
| 555 | 26844991 |
US |
87 | 1 |
Bronchospasm, Asthma, Cough, Incorrect dose administered, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 556 | 26845041 |
CA |
43 | 2 |
Type 2 diabetes mellitus, Alopecia, Condition aggravated, Hand deformity, Hypoaesthesia, Muscle injury, Osteoarthritis, Pemphigus, Pericarditis, Stomatitis, Arthropathy, Fatigue, Helicobacter infection, Hypertension, Inflammation, Lip dry, Live birth, Liver injury, Lower respiratory tract infection, Maternal exposure during pregnancy, Mobility decreased, Musculoskeletal pain, Nail disorder, Nasopharyngitis, Obesity, Psoriatic arthropathy, Rheumatoid arthritis, Swelling, Systemic lupus erythematosus, Wound infection, Urticaria, Wheezing, Abdominal pain, Anti-cyclic citrullinated peptide antibody positive, Anxiety, Asthma, Autoimmune disorder, C-reactive protein abnormal, |
||||
ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, CANDESARTAN, CANDESARTAN, CANDESARTAN, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, OXYCODONE, OXYCODONE, OXYCODONE, OXYCODONE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PREGABALIN, PREGABALIN, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, CALCIUM CARBONATE, CALCIUM CARBONATE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ATOMOXETINE HYDROCHLORIDE, BOTULINUM TOXIN TYPE A, BOTULINUM TOXIN TYPE A, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, BUPRENORPHINE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, LAMOTRIGINE, LAMOTRIGINE, PYRIDOXINE HYDROCHLORIDE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, SARILUMAB, SARILUMAB, SARILUMAB, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, ERGOCALCIFEROL, CALCIUM CARBONATE, CALCIUM CARBONATE, ERGOCALCIFEROL, DEXPANTHENOL, MAGNESIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, PHENYLEPHRINE HYDROCHLORIDE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, LORAZEPAM, CYANOCOBALAMIN, ICOSAPENT ETHYL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LANSOPRAZOLE, |
||||
| 557 | 26845071 |
US |
2 | |
Asthma, |
||||
DENOSUMAB, |
||||
| 558 | 26845230 |
US |
58 | 2 |
Asthma, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 559 | 26845309 |
US |
2 | |
Asthma, |
||||
DUPILUMAB, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, BUSPIRONE HYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, ALPRAZOLAM, |
||||
| 560 | 26845322 |
US |
40 | 1 |
Asthma, Nasopharyngitis, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 561 | 26845332 |
US |
72 | 1 |
Asthma, Chest discomfort, Secretion discharge, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 562 | 26845427 |
US |
71 | 1 |
Choking, Secretion discharge, Asthma, Product prescribing error, |
||||
DUPILUMAB, |
||||
| 563 | 26845491 |
CA |
81 | 2 |
Localised infection, Asthma, |
||||
DUPILUMAB, DUPILUMAB, UMECLIDINIUM, UMECLIDINIUM, UMECLIDINIUM, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
| 564 | 26845863 |
US |
2 | |
Asthma, |
||||
MEPOLIZUMAB, |
||||
| 565 | 26839690 |
PR |
52 | 2 |
Pneumonia, Asthma, |
||||
DIROXIMEL FUMARATE, |
||||
| 566 | 26839808 |
US |
75 | 2 |
Neoplasm malignant, Fatigue, Brain fog, Anaemia, Blood iron decreased, Asthma, Cough, |
||||
DUPILUMAB, |
||||
| 567 | 26840259 |
US |
61 | 2 |
Asthma, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 568 | 26840293 |
US |
38 | 2 |
Hyperhidrosis, Hypersensitivity, Asthma, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, DUPILUMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, AZELASTINE HYDROCHLORIDE, AZELASTINE, IVABRADINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, EPINEPHRINE, ADRENALINUM, FLUVOXAMINE MALEATE, LEVALBUTEROL HYDROCHLORIDE, LIDOCAINE 4%, LIDOCAINE, LIDOCAINE 5%, LIDOCAINE, 0.5%, LIDOCAINE HCL 3%, LIDOCAINE 0.5%, MAGNESIUM, MIDODRINE HYDROCHLORIDE, MONTELUKAST SODIUM, MONTELUKAST, NALTREXONE HYDROCHLORIDE, BEMPEDOIC ACID, FAMOTIDINE, BECLOMETHASONE DIPROPIONATE, ATOGEPANT, THYROID, IODIUM,BADIAGA,FUCUS VESICULOSUS,CALCAREAARSENICUM IODATUM, THYROIDINUM,CARBONICA,PULSATILLA,BARYTA CARBONICA,, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, UBROGEPANT, ERGOCALCIFEROL, LEVALBUTEROL TARTRATE, CETIRIZINE HYDROCHLORIDE, |
||||
| 569 | 26840566 |
GB |
||
Asthma, Product label counterfeit, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 570 | 26840846 |
US |
50 | 2 |
Sinusitis, Asthma, |
||||
DUPILUMAB, |
||||
| 571 | 26840910 |
US |
1 | |
Influenza, Asthma, |
||||
OMALIZUMAB, OMALIZUMAB, |
||||
| 572 | 26841392 |
US |
74 | 1 |
Accidental exposure to product, Exposure via skin contact, Asthma, |
||||
DUPILUMAB, |
||||
| 573 | 26841397 |
CA |
43 | 2 |
Folliculitis, Facet joint syndrome, Joint range of motion decreased, Impaired healing, Asthma, Peripheral swelling, Lung disorder, Fatigue, Deep vein thrombosis postoperative, Migraine, Musculoskeletal pain, Peripheral venous disease, Lower respiratory tract infection, Adjustment disorder with depressed mood, Night sweats, Lip dry, Autoimmune disorder, Bursitis, Chest pain, Irritable bowel syndrome, Dyspnoea, General physical health deterioration, Urticaria, Alopecia, Abdominal discomfort, Obesity, Inflammation, Confusional state, Gait disturbance, Gastrointestinal disorder, Blister, Hepatic enzyme decreased, Adverse drug reaction, Gait inability, Breast cancer stage II, Pulmonary fibrosis, Pneumonia, Depression, Condition aggravated, C-reactive protein abnormal, Stomatitis, Arthralgia, Blood cholesterol increased, Arthropathy, Infection, Dry mouth, Contusion, Osteoarthritis, Maternal exposure during pregnancy, Asthenia, Dyspepsia, Nausea, Anxiety, Muscle injury, Discomfort, Decreased appetite, Amnesia, Duodenal ulcer perforation, Paraesthesia, Exposure during pregnancy, Mobility decreased, Wound infection, Muscle spasms, Memory impairment, Weight increased, Ear pain, Grip strength decreased, Abdominal pain upper, Fibromyalgia, Delirium, Contraindicated product administered, Off label use, Incorrect route of product administration, |
||||
ALBUTEROL SULFATE, ALBUTEROL, ALENDRONATE SODIUM, CALCIUM CARBONATE, ANTACID, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, INFLIXIMAB, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, LEFLUNOMIDE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, OXYCODONE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, CALCIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, OXYCODONE HYDROCHLORIDE, OXYCODONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, LEFLUNOMIDE, RITUXIMAB, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, CELECOXIB, CERTOLIZUMAB PEGOL, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, SECUKINUMAB, SECUKINUMAB, |
||||
| 574 | 26841529 |
CA |
43 | 2 |
Abdominal discomfort, Adjustment disorder with depressed mood, Asthma, Chest pain, Contusion, Drug-induced liver injury, Dyspepsia, Gait inability, Inflammation, Lip dry, Lower respiratory tract infection, Lung disorder, Migraine, Muscle spasms, Paraesthesia, Prescribed underdose, Type 2 diabetes mellitus, Upper respiratory tract infection, Urticaria, Visual impairment, Vomiting, Weight decreased, Weight increased, Wheezing, Wound, Wound infection, |
||||
MESALAMINE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, AZATHIOPRINE, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CHLORHEXIDINE GLUCONATE, CHLORHEXIDINE GLUCONATE, DESOXIMETASONE, DESOXIMETASONE, GOLIMUMAB, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, INFLIXIMAB, INFLIXIMAB, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MORPHINE SULFATE, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, APREMILAST, APREMILAST, APREMILAST, OXYCODONE, PREGABALIN, SALICYLIC ACID, MEDICATED CORN REMOVERS, LIQUID WART REMOVER, ULTRA THIN CORN REMOVERS, EXTRA THICK CALLUS REMOVERS, MEDICATED WART REMOVERS, CORN AND CALLUS REMOVER KIT, WART REMOVERS, WART REMOVER LIQUID, MEDICATED CALLUS REMOVERS, WART REMOVER GEL, MEDICATED PLANTAR WART REMOVER, MEDICATED CALLUS REMOVERS EXTRA THICK, MEDICATED CORN REMOVER, WART REMOVER, CLEAR MEDICATED CORN REMOVERS, CORN REMOVERS, BOSYE BENEFITING HAIR LOTION, LIQUID CORN AND CALLUS REMOVER, WART REMOVER MEDICATED DISCS, WART REMOVER GEL TUBE, SALICYLIC ACID 12%, CALLUS REMOVERS, CORN AND CALLUS REMOVER, GEL CORN REMOVER, ASTRINGENT, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TRAMADOL HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRICLOSAN, USTEKINUMAB, TOFACITINIB, TOFACITINIB, |
||||
| 575 | 26841653 |
CA |
2 | |
Pneumonia, Asthma, |
||||
IPRATROPIUM BROMIDE, MONTELUKAST SODIUM, TIOTROPIUM BROMIDE INHALATION SPRAY, TIOTROPIUM BROMIDE INHALATION SPRAY, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
| 576 | 26841702 |
US |
39 | 2 |
Nasopharyngitis, Asthma, |
||||
DUPILUMAB, |
||||
| 577 | 26842024 |
50 | 2 | |
Asthma, |
||||
GADOBUTROL, |
||||
| 578 | 26842063 |
US |
87 | 2 |
Asthma, Oxygen saturation decreased, Spondylitis, Condition aggravated, |
||||
DUPILUMAB, FAMOTIDINE, FLUTICASONE PROPIONATE, GABAPENTIN, LOSARTAN, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, ROPINIROLE, TORSEMIDE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 579 | 26842070 |
US |
2 | |
Asthma, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 580 | 26842098 |
US |
80 | 2 |
Dyspnoea, Contusion, Injection site haemorrhage, Asthma, Extra dose administered, Therapeutic response decreased, |
||||
DUPILUMAB, ALBUTEROL SULFATE, ALBUTEROL SULFATE, PREDNISONE, |
||||
| 581 | 26842128 |
US |
61 | 2 |
Asthma, Dyspnoea, Abdominal distension, Arthralgia, Gastrointestinal disorder, |
||||
ROFLUMILAST, LOSARTAN POTASSIUM, LOSARTAN, MELOXICAM, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, DUPILUMAB, CALCIUM, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, ALBUTEROL SULFATE, SERTRALINE HYDROCHLORIDE, LORAZEPAM, AMLODIPINE BESYLATE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, LEVOTHYROXINE SODIUM, AMLODIPINE BESYLATE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, TOBRAMYCIN, ERGOCALCIFEROL, AZTREONAM, |
||||
| 582 | 26842252 |
GB |
45 | 1 |
Asthma, Medication error, Drug ineffective, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 583 | 26842309 |
US |
1 | |
Nasal congestion, Asthma, Drug ineffective, |
||||
BENRALIZUMAB, BENRALIZUMAB, |
||||
| 584 | 26842405 |
65 | 1 | |
Antineutrophil cytoplasmic antibody positive, Anxiety, Arteriosclerosis, Arteriosclerosis coronary artery, Asthma, Capillaritis, Condition aggravated, Conjunctivitis allergic, Death, Dust allergy, Dyspnoea, Eosinophilic granulomatosis with polyangiitis, Forced expiratory volume decreased, Full blood count abnormal, Haemoptysis, Hypothyroidism, Hypoxia, Lung disorder, Mite allergy, Mycotic allergy, Neuritis, Neurological symptom, Nodule, Normochromic normocytic anaemia, Obstructive airways disorder, Pain in extremity, Productive cough, Pulmonary alveolar haemorrhage, Pulmonary embolism, Pulmonary fibrosis, Pulmonary vasculitis, Respiratory symptom, Sleep disorder, Sleep disorder due to a general medical condition, Spirometry abnormal, Therapeutic product effect incomplete, Thrombosis, Total lung capacity abnormal, Vasculitis, Wheezing, Product use in unapproved indication, |
||||
ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, BETAMETHASONE DIPROPIONATE, |
||||
| 585 | 26842521 |
EU |
39 | 2 |
Paraplegia, Shrinking lung syndrome, Erythema, Asthma, |
||||
OXYCODONE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, IVABRADINE, HYDROXYCHLOROQUINE, TIZANIDINE HYDROCHLORIDE, TACROLIMUS, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, FOLIC ACID, |
||||
| 586 | 26842798 |
US |
34 | 2 |
Asthma, |
||||
DUPILUMAB, TEZEPELUMAB-EKKO, |
||||
| 587 | 26842831 |
US |
52 | 2 |
Asthma, Lip pruritus, Throat irritation, Fatigue, Injection site pain, Hypersensitivity, |
||||
DUPILUMAB, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, FLUTICASONE PROPIONATE, HYDROCHLOROTHIAZIDE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 588 | 26843195 |
AU |
||
Asthma, |
||||
BENRALIZUMAB, BENRALIZUMAB, |
||||
| 589 | 26843546 |
CA |
69 | 1 |
Respiratory syncytial virus infection, Asthma, Drug ineffective, |
||||
BENRALIZUMAB, BENRALIZUMAB, UMECLIDINIUM, PREDNISONE, ALBUTEROL SULFATE, ATORVASTATIN CALCIUM, GABAPENTIN, AMLODIPINE BESYLATE, |
||||
| 590 | 26843570 |
US |
1 | |
Dry eye, Asthma, Intentional dose omission, |
||||
DUPILUMAB, |
||||
| 591 | 26843906 |
US |
58 | 2 |
Multiple allergies, Chronic obstructive pulmonary disease, Asthma, |
||||
DUPILUMAB, |
||||
| 592 | 26844121 |
CA |
2 | |
Dyspnoea, Pneumonia, Fatigue, Asthma, |
||||
MONTELUKAST SODIUM, MONTELUKAST, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ROSUVASTATIN CALCIUM, MOXIFLOXACIN HYDROCHLORIDE, AMOXICILLIN, ALENDRONATE SODIUM, BUDESONIDE, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, MEPOLIZUMAB, TERBUTALINE SULFATE, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 593 | 26844448 |
US |
64 | 2 |
Asthma, Productive cough, Dyspnoea, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 594 | 26844712 |
CA |
34 | 2 |
Asthma, Chest pain, Cough, Dyspnoea, Malaise, Nasal oedema, Oedema, Pain, Pneumonia, Respiratory tract infection, Vomiting, Wheezing, Drug hypersensitivity, |
||||
MOXIFLOXACIN HYDROCHLORIDE, OMALIZUMAB, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, ROSUVASTATIN CALCIUM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, CALCIUM, CLONAZEPAM, ERGOCALCIFEROL, PREDNISONE, RISEDRONATE SODIUM, RITUXIMAB, MONTELUKAST SODIUM, MONTELUKAST, THEOPHYLLINE, THEOPHYLLINE ANHYDROUS, TRAMADOL HYDROCHLORIDE, NEOMYCIN OINTMENT, POLYMYXIN B SULFATE, |
||||
| 595 | 26844784 |
US |
||
Asthma, Dyspnoea, Fatigue, Headache, Pollakiuria, Thirst, Product prescribing issue, |
||||
DROSPIRENONE, |
||||
| 596 | 26844836 |
US |
12 | 1 |
Illness, Asthma, Eosinophilic oesophagitis, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 597 | 26848761 |
65 | 2 | |
Asthma, |
||||
MEPOLIZUMAB, |
||||
| 598 | 26834541 |
BR |
1 | |
Asthma, Dyspnoea, Product availability issue, |
||||
TEZEPELUMAB-EKKO, TEZEPELUMAB-EKKO, |
||||
| 599 | 26834588 |
CA |
2 | |
Noninfective encephalitis, Brain injury, Respiratory distress, Asthma, Stress, Product availability issue, |
||||
FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, TIOTROPIUM BROMIDE INHALATION SPRAY, ALBUTEROL SULFATE, PREDNISONE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 600 | 26834749 |
US |
47 | 2 |
Asthma, Injection site reaction, |
||||
DUPILUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30